NBA superstar Grant Hill, also an Atlanta Hawks co-owner, and African American health advocate, has teamed up with  Dendreon to combat the prostate cancer racial disparities experienced by African American men.  He discusses, along with Cancer ABCs CEO Joel Nowak, how men, particularly African American men, can combat the disparities.   They focus on how a man can develop their own playbook to beat prostate cancer,  what role a man should play with his doctor and the importance of becoming...

Overall survival and cancer-specific survival for those with node-positive prostate cancer treated with surgery lived longer than those who elected radiation treatment.  Men diagnosed with node positive prostate cancer need to decide if they want to include a targeted treatment to their prostate gland along with a systemic treatment like hormonal therapy.  Most men who elect to include a targeted therapy will choose between either surgery or radiation.  A retrospective observational study...

https://ard.bmj.com/content/early/2021/08/22/annrheumdis-2021-220597  As per the link above, individuals taking the drug methotrexate experience an up to 62% reduced rate of an immunological response when given a mRNA Covid-19 vaccination like to Pfizer and Moderna vaccines.  This finding suggests that patients on methotrexate may need alternate vaccination strategies such as additional doses of vaccine, dose modification of methotrexate or even a temporary discontinuation of this drug. In...

When you are first diagnosed with cancer, when the doctor says to you have cancer, you are likely to have many different responses. Among these first possible responses are fear, apprehension, disbelief, sadness, anger, dread, or even denial. Any and all of these reactions are reasonable and normal. The question is how do you chose to deal with these feelings?   Everyone's cancer is different and how we as individuals deal with our cancer is also different. However, developing a specific...

Joel Nowak and Shane Norris discuss his unusual Covid Pandemic Journey with a new prostate cancer diagnosis.  Shane, a well respected music producer and gig worker, joined with other New Orleans artists to raise funds for out of work New Orleans musicians.  As he begun to create a fund raising vehicle he was diagnosed with prostate cancer.   Shane shares the experience he had navigating the Covid pandemic as he searched for the prostate cancer treatment that he felt best suited his needs. ...

Radiopharmaceutical scans (PETS) are a vital tool in our fight against cancer. These special PET scans allow us to make earlier cancer diagnoses while a cancer is still contained in the original organ.   With an earlier diagnosis, treatments can still...

Joel T Nowak from Cancer ABCs discusses with Dr. Rana McKay, Associate Professor of Medicine at the Moores Cancer Center at the University of California in San Diego,  her recently published article that analysizes real world data that demonstrates that...

Spare Trial indicates it might be possible to stop hormone therapy if you are also taking Zytiga to treat your prostate cancer.

John Harrison describes his journey dealing with significant side effects of prostate cancer salvage radiation. He has undergone two rounds of Hyperbaric Treatments as well as having a colostemy. John also just finished a Phase II Cinical Trial to treat his recurrent prostate cancer

Genetic testing has become very important for people with cancer, especially for people with metastatic cancer. Neither state or federal laws adequately protect us from discrimination if we test positively for any genetic predisposition for cancer or its progression.

Emily Rencsok discusses her publication about the continuing racial disparities in both prostate cancer clinical trials and in the treatment of racially disparate populations.

Joel Nowak discusses how one doctor, Dr. Emmanuel Antonarakis from The Johns Hopkins Hospital has modified his prostate cancer treatments in the era of the coronavirus.  Joel shares how Dr. Antonarakis has moved to using telemedicine when possible, the...

We discuss the immunotherapy Provenge (sipuleucel-T) focusing on its survival advantages for men with advanced metastatic prostate cancer.

Why men can become incontinent after a radical prostatectomy to treat their prostate cancer and how they can reverse this negative side effect.

Anson Tharayanil describes the Oncotype DX Genomic Prostate Score test for men who are diagnosed with low and moderate risk prostate cancer - it is a tool to help them decide if Active Surveillance would be a good treatment decision.

A podcast about the Genomic Health test, The Oncotype DX ARV-7 Nucleus Detect Test, to determine a man with castrate resistant metastatic prostate cancer sensitivity to Xtandi, Zytiga and Erleada.

Learn how and why prostate cancer metastizes (forms tumors) and how oligometastatic prostate cancer (fewer than five tumors in the pelvis) might be treated for the cure.

Mark Hall despite being diagnosed with very advanced and aggressive prostate cancer shares his journey which puts him in a long term remission.

This podcast will provide you with an insight into how to talk with and provide help and support to a person with cancer.

This episode offers men with prostate cancer an explanation about what is hormone therapy (ADT), how it is achieved and how to use "grassroots" methods to help control the side effects.

Joel Nowak from Cancer ABCs interviews Michael Singer, a male breast cancer thriver. Michael, diagnosed at age 50, shares his journey and his advocacy as a man with breast cancer.  Three years before learning that he had breast cancer his sister, with whom he lived, was diagnosed with metastatic breast cancer. She succumbed to the disease one year after receiving the diagnosis. So, when Michael learned about his diagnosis, he assumed that he too would live for only one year. Like many...

Dr. Corrie painter talks to Joel Nowak about the Broad Institute's Angiosarcoma project and shares her emotional experience of being diagnosed and making treatment choices when there are no good alternatives.

Joel T Nowak interviews Dr. Maryanne Sadar, who has developed a novel drug target, an investigational treatment, that is a first in class hormone therapy operating on the N Terminal Domain of the androgen receptor. The investigational treatment, Epi-506, is being tested on men with advanced, metastatic prostate cancer.  Dr. Sadar describes how the drug target was first identified then how it was tested in cell lines, then animals and now in humans. She also describes the process of having to...

Dr. Eli Van Allen from the Broad Institute is interviewed by Joel T. Nowak from Cancer ABCs about the Metastatic Prostate Cancer Project